https://www.avient.com/sites/default/files/resources/Innovation_Day_-_May_2014_0.pdf
Patricia Hubbard Global Technical Director Specialty Engineered Materials PolyOne Corporation Page 6 Agenda Time Topic Presenter 8:00-8:15 AM Welcome and Introduction Robert M.
Patterson 8:15-8:30 AM Financial Highlights and Goals Bradley C.
Richardson 8:30-8:45 AM Innovating for the Future Dr.
https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520-%2520Jefferies%2520Conference%2520-%25208%253A7%253A2018.pdf
7$�( ���1 $&�.�$() $3��� �8/ ��&�"'�� ��!
$8 ()=>>2 6?
$� �8 �� �$&�!
https://www.avient.com/resource-center?document_type=221&all=1
Gravi-Tech™ Density Modified Formulations and Versaflex™ TPEs for Cosmetics Packaging (Chinese)
Gravi-Tech™ Density Modified Formulations and Versaflex™ TPEs for Cosmetics Packaging
Enhance your cosmetic packaging with Gravi-Tech and Versaflex solutions
https://www.avient.com/sites/default/files/2021-03/avient-march-ir-fermium_0.pdf
You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission.
These investments also consider our global footprint, and we are positioned very well and strategically from a regional perspective. 8 Growth Drivers 2020 Revenue ($ Millions) Long-Term Growth Rate Sustainable Solutions $ 560 8–12% Healthcare 555 8–10% Composites / 5G 212 10% Growth in Emerging Regions 672 5% Other (GDP growth) 1,784 2–3% Pro Forma Avient $ 3,783 6.5% 2020 PE RF O RM AN CE 2020 HIGHLIGHTS 10 • Completed transformational Clariant Masterbatch acquisition and created new brand name Avient • Increased pro forma adjusted EPS 11% from $1.74 to $1.93 as an essential supplier during the pandemic and due to growth in demand for consumer applications • Specialty Engineered Materials delivered record operating income on gains from composites • Achieved record free cash flow, increased dividend for 10th year in a row and delevered from 3.5x to 2.7x net debt to pro forma adjusted EBITDA • Culture is everything: Certified as a Great Place to Work® $133 $150 2019PF 2020PF 10% 23%8% 21% 4% 15% 2006 2020PF Healthcare Consumer Packaging Avient Portfolio Transformation 22% 59% CLARIANT MASTERBATCH: TRANSFORMATIONAL ACQUISITION 11 Clariant MB EBITDA Growth Purchase Price Multiple 10.8 9.6 6.5 2019PF 2020PF 2020PF w/ Full Synergies x x x • Acquisition of Clariant Masterbatch significantly expands presence in healthcare, packaging and consumer end markets • Strength of portfolio – 13% EBITDA growth as an essential supplier in COVID response and recovery • Acquisition completed on July 1, 2020 for $1.4 billion.
Whether an additional line at an existing manufacturing plant, or a new facility in a growing region, we ramp-up quickly and cost-efficiently. 24 Capex / Revenue 2021E (%) AVIENT IS ASSET LIGHT Avient Specialty Formulators Other Chemical/Specialty Companies 2 3 2 2 3 3 3 4 3 3 4 4 4 5 5 5 5 7 7 8 23 A vi en t A vi en t (E xc l.
https://www.avient.com/sites/default/files/2021-12/PREPERM _ Edgetek Low-loss Dielectric Thermoplastics Technical Bulletin.pdf
KEY PROPERTIES AND PERFORMANCE FR GRADES H GRADES PEEK GRADES LCP GRADES FLEX GRADES PROPERTIES CONDITION ISO UNIT PPE400FR PPE700FR PPE950FR PPE1200FR H1500HF H2300HF PEEK700 PEEK900 PEEK1000 PEEK1200 LCP650 LCP800 LCP950 FLX400 FLX700 FLX1100 Dielectric Constant (Dk) 2.4 GHz 4.0 7.0 9.5 12.0 15.0 23.0 7.0 9.0 10.0 12.0 6.5 8.0 9.5 4.0 7.0 11.0 Loss Tangent (Df) 2.4 GHz 0.0030 0.0039 0.0042 0.0045 0.0010 0.0037 0.0024 0.0025 0.0024 0.0027 0.0043 0.0045 0.0047 0.0010 0.0009 0.0012 Density 1183 g/cm3 1.44 1.97 2.20 2.50 2.60 3.40 1.94 2.20 2.30 2.40 2.00 2.15 2.30 1.52 1.93 2.50 Melt Flow Index (MFI) 5 kg, 300 °C (unless noted) 1113 g/10 min 17 12 13 5 5 8 15 @ 380 °C 13 @ 380 °C 10 @ 380 °C 6 - - - 11 @ 230 °C 2 @ 230 °C 0.3 @ 230 °C Tensile Strength at Break 23 °C/73 °F 527 MPa 47 52 44 45 23 40 64 62 65 67 75 80 75 11 17 25 Flexural Modulus 23 °C/73 °F 178 MPa 3100 4500 - 9300 2100 5000 6200 7600 9200 11000 8000 8500 8500 1400 1600 2900 Unnotched Izod 23 °C/73 °F 180 kJ/m2 NB 42 20 9 17 10 28 25 18 15 31 20 12 NB NB NB -20 °C/-4 °F 180 kJ/m2 - - - - 17 10 - - - - - - - - - Notched Izod 23 °C/73 °F 180 kJ/m2 14 6 4 3 5 4 6 4 4 4 10 6 4 59 23 13 -20 °C/-4 °F 180 kJ/m2 - - - - 5 4 - - - - - - - - - - STANDARD GRADES RADOME GRADES PROPERTIES CONDITION ISO UNIT PPE260 PPE300 PPE320 PPE350 PPE400 PPE440 PPE500 PPE650 PPE800 PPE950 PPE1200 RS260 RB260 RS265FR Dielectric Constant (Dk) 2.4 GHz 2.6 3.0 3.2 3.5 4.0 4.4 5.0 6.5 8.0 9.5 12.0 2.6 2.6 2.7 Loss Tangent (Df) 2.4 GHz 0.0009 0.0009 0.0010 0.0009 0.0009 0.0009 0.0009 0.0009 0.0009 0.0009 0.0010 0.0009 0.0012 0.0032 Density 1183 g/cm3 1.07 1.18 1.21 1.27 1.43 1.50 1.62 1.86 2.10 2.20 2.40 1.06 1.08 1.09 Melt Flow Index (MFI) 5 kg, 300 °C 1113 g/10 min 15 15 16 14 14 14 15 11 10 4 2 21 16 25 Tensile Strength at Break 23 °C/73 °F 527 MPa 40 45 47 50 50 48 45 43 37 37 36 50 42 52 Flexural Modulus 23 °C/73 °F 178 MPa 2700 2400 2000 2600 2800 2700 2600 2600 2300 2600 2600 2200 2200 2600 Unnotched Izod 23 °C/73 °F 180 kJ/m2 NB NB NB NB NB NB NB NB 50 28 24 NB NB NB -20 °C/-4 °F 180 kJ/m2 NB NB NB NB NB NB NB 50 47 27 25 NB NB NB Notched Izod 23 °C/73 °F 180 kJ/m2 8 55 69 35 22 20 15 9 8 5 4 19 14 11 -20 °C/-4 °F 180 kJ/m2 8 15 20 14 12 10 9 8 8 5 4 10 12 10 PREPERM™ SERIES PROPERTIES CONDITION ISO UNIT 8027 8025 8037 8019 8028 8026 8044 8029 8041 8045 8048 8036 8056 8031 Dielectric Constant (Dk) 1 GHz, 23 °C 3.0 3.1 3.4 3.6 3.8 4.4 4.8 5.3 5.4 5.9 6.0 7.0 7.3 9.0 Loss Tangent (Df) 1 GHz, 23 °C 0.0012 0.0012 0.0008 0.0010 0.0010 0.0010 0.0004 0.0008 0.0006 0.0002 0.0006 0.0007 0.0002 0.0007 Density 1183 g/cm3 1.25 1.26 1.35 1.39 1.45 1.59 1.72 1.75 1.79 1.89 1.88 2.06 2.086 2.25 Melt Flow Index (MFI) 5 kg, 300 °C 1113 g/10 min 16 19 10 11 15 13 10 10 15 15 19 10 18 4.7 Tensile Strength at Break 23 °C/73 °F 527 MPa 59 54 54 62 59 54 52 58 52 45 49 45 37 38 Flexural Modulus 23 °C/73 °F 178 MPa 2780 2560 2850 3060 3350 3700 3157 4300 4320 3137 4150 3370 2560 4200 Notched Izod 23 °C/73 °F 180 kJ/m2 15.3 14 14.8 14 12.6 10.4 9.9 8.6 7.4 7.9 6.6 7.1 6.2 6.8 EDGETEK™ 7600 SERIES Copyright © 2021, Avient Corporation.
https://www.avient.com/sites/default/files/2022-11/AVNT Q3 2022 Earnings Presentation - Website Final.pdf
Purchase price multiple rapidly declining on strength of business and synergy capture 7 $133 $201 2019PF 2022E 7 Clariant Color EBITDA Growth Purchase Price Multiple 10.8x 7.0x 6.4x 2019PF 2021 2022E w/ Full Synergies (1) (1) 11.9% 16.3% 2019PF 2022E EBITDA Margins (1) CLARIANT COLOR: TRANSFORMATIONAL ACQUISITION ($ in millions) (1) Financial information is pro forma to include a full year of Clariant Color business SUNBELT PVC Resins DSS 20 Acquisitions $4.8B Investment $2.7B of Annual Revenue 5 Divestments $2.3B Proceeds TPE PP&S HISTORIC SPECIALIZATION THROUGH M&A 8 Distribution DSM Protective Materials BOLT-ON ACQUISITION HISTORY 9 Commercial Resources Operating Income ($ in millions) Operating Margins 259 363 At Acquisition 2022E $40 $139 At Acquisition 2022E 9% 22% At Acquisition 2022E Established Acquisitions (> 7 years) + 40% + 248% + 1300 bps I N V E S T T O G R O W SPECIALTY TRANSFORMATION T O D A Y 7% 46% 67% 86% 100% 0% 20% 40% 60% 80% 100% 2005 2010 2019 2021 2022 PF % o f A d ju st ed E B IT D A • Commodity JVs • Distribution • Performance Products & Solutions • Specialty Businesses (1) Adjusted EBITDA is EBITDA excluding corporate costs and special items (2) Pro forma for the acquisition of Dyneema® and divestiture of Distribution (1 ) (2) 10 Healthcare 4% Packaging 8% Consumer 10% Building & Construction 43% Industrial 15% Transportation 14% Energy 4% Telecom. 2% 2006 2022 Pro Forma Healthcare 8% Packaging 23% Consumer 21% Building & Construction 10% Industrial 15% Transportation 9% Energy 4% Telecom. 4% Defense 6% END MARKET FOCUS ON LESS CYCLICAL INDUSTRIES 11 14.8% 17.6% 21.0% 2018 2020 2022 PF 1.8% 2006 15.3% 16.2% 17.0% 2018PF 2020PF 2022E CAI 2.7% 2006 SEM SPECIALTY EBITDA MARGIN EXPANSION 12 • Portfolio transformation accelerates growth in less cyclical, higher margin end markets • Investments in our composites platform continue to drive margin expansion (1) (1) (1) 2018 and 2020 financial information is pro forma to include a full year of Clariant Color acquisition PORTFOLIO EVOLUTION OVER THE YEARS 13 Adj.
OPS) 16 Sales Adjusted EBITDA $818 $823 2021 2022 + 1% Adjusted EPS + 8% - 3% (in millions) (in millions) (+ 9% excluding FX) (+ 18% excluding FX) (+ 5% excluding FX) Q3 EBITDA BRIDGE (PRO FORMA TOTAL COMPANY) 17 Price increases more than offset raw material and supply chain impacts $ millions CAI: Price / Mix 68 Inflation (44) SEM: Price / Mix 41 Inflation (26) Net Price Benefit 39 Wage and Energy Inflation (14) Clariant Color Integration Synergies 6 Incentives, Other Employee Costs 14 FX (11) Q3 2022 $137 Adjusted EBITDA Q3 2021 $ 142 Demand (39) Q3 2022 SEGMENT PERFORMANCE 18 CAI $587 $566 Sales ($ in millions) $93 $93 EBITDA SEM Pro Forma $326 $319 Sales $70 $62 EBITDA (+ 4% excluding FX) - 4% - 2% (+ 5% excluding FX) Flat (+ 7% excluding FX) - 11% (- 7% excluding FX) $500 $585 Cont.
Sales EBITDA Specialty Engineered Materials Color Additives and Inks $585M$3,635M (1) Transportation 9% Healthcare 8% 23 C O L O R , A D D I T I V E S & I N K S 2022 REVENUE | $2 .3 B ILL ION US & Canada 35% EMEA 40% Asia 20% Latin America 5% END MARKET REGION 24 Packaging 33% Consumer 22% Healthcare 9% Industrial 15% Transportation 8% Building & Construction 11% Telecommunications 1% Energy 1% Figures represent 2022 full year estimates S P E C I A LT Y E N G I N E E R E D M AT E R I A L S 2022 PRO FORMA REVENUE | $1 .3 B ILL ION END MARKET US & Canada 50% EMEA 35% Asia 15% REGION 25 Figures represent 2022 full year estimates Packaging 5% Consumer 19% Healthcare 8%Industrial 16% Transportation 10% Telecommunications 10% Energy 9% Defense 15% Building & Construction 8% Packaging 31% Consumer 28% Healthcare 8% Industrial 13% Building & Construction 5% Telecommunications 3% Energy 2% Defense 1% Asia (20% of sales) Transportation 9% 2022 PROFORMA AVIENT REGIONAL SALES BY END MARKET Packaging 29% Consumer 13% Healthcare 5% Industrial 17% Building & Construction 11% Energy 5% Defense 7% EMEA (35% of sales) Transportation 10% Packaging 14% Consumer 23% Healthcare 11% Industrial 15% Building & Construction 12% Energy 5% Defense 7% US & Canada (40% of sales) Transportation 7% Packaging 49% Consumer 22% Healthcare 8% Industrial 9% Building & Construction 6% Telecommunications 1% LATAM (5% of sales) Transportation 5% Telecommunications 3%Telecommunications 6% Figures represent 2022 full year estimates Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.
https://www.avient.com/sites/default/files/resources/PDI_Case_Study_-_Medical_Device_0.pdf
PDICaseStudy.indd 8.5 in 11.6875 in 8 .75 in 11.9375 in 8 .25 in 11 in PDI Solution Boosts Long-Term Medical Device Performance Spinal disc replacement manufacturer relies on quality analysis and manufacturing solutions from Polymer Diagnostics to help its breakthrough product reach far beyond durability requirements.
Asset No. 76593C M Y K PDICaseStudy.indd REMAY 76593 trim: 8.5in x 11in and 8.25in x 11.6875in bleed: 8.75in x 11.9375in Digital/IAM 8.5 in 11.6875 in 8 .75 in 11.9375 in 8 .25 in 11 in www.polymerdiagnost ics.com Copyright © 2008, Polymer Diagnostics Inc.
https://www.avient.com/sites/default/files/2021-10/remafin-ep-white-masterbatches-for-pharma-application-bulletin_0.pdf
KEY CHARACTERISTICS • Manufactured under change control principles beyond CAS number (similar level as MEVOPUR concentrates), reducing risk of change • Free from animal-derived substances and phthalates • Suitable for blown film, injection molding, blow molding and extrusion REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 - USP chapters , including Class VI, a requirement for ophthalmic and nasal drugs - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities - USP and USP light transmission • Registered Drug Master File (Type III) • Food contact compliance established with FDA/EU* APPLICATION BULLETIN CARRIER MATERIAL PIGMENT CONTENT/TYPE LIGHT FASTNESS THERMAL STABILITY PRODUCT CODE HDPE 50% TiO2 8 300°C PH00075525 LLDPE 60% TiO2 8 300°C PL00075542 LLDPE 70% TiO2 8 300°C PL00075545 PP 50% TiO2 8 300°C PP00075717 Healthcare use limitations apply—see below.
https://www.avient.com/sites/default/files/2021-01/avient-finland-oy-trade-register-extract-eng-dec-1-2020.pdf
+358 (0)29 509 5000 registry@prh.fi Page: 1 (2) Business ID: 2046676-4 Date and time of creating the document: 01.12.2020 08:37:55 TRANSLATION OF THE EXTRACT FROM THE TRADE REGISTER, ELECTRONIC 01.12.2020 08:37:54 the details in the register Identifiers Name Avient Finland Oy Business ID 2046676-4 Entered in the register 31.03.2007 Company type Limited company Contact details: Postal address Äyritie 8 E 01510 Vantaa Street address Äyritie 8 E 01510 Vantaa Email tina.ahlquist@clariant.com Telephone 0106808500 Fax 0106808509 Name details Name Avient Finland Oy Auxiliary company name Drycolor Registered office Vantaa Share capital Share capital 169.000,00 € Number of shares 1 000 pcs Nominal value of a share 169,00 € Financial period Financial period 01.01 - 31.12 Financial statements The last financial statements submitted 01.01.2019 - 31.12.2019 Representation Page: 2 (2) Business ID: 2046676-4 Statutory representation: Under the law, the Board of Directors represents the company.
Representation based on position: By the Chair of the Board and the Managing Director, each on their own, and by any two Board members jointly Persons role surname, first name(s) / company name date of birth / identity code citizenship Chair of the Board of Directors Merklein, Norbert 03.05.1964 Citizen of Germany Member of the Board of Directors Norén, Jenny Eva Kristina 18.06.1975 Citizen of Sweden Member of the Board of Directors Smeds, Jan-Håkan 22.03.1961 Citizen of Finland Member of the Board of Directors Vetter, Alexander Helmut 04.07.1968 Citizen of Germany Managing Director Norén, Jenny Eva Kristina 18.06.1975 Citizen of Sweden Auditor PricewaterhouseCoopers Oy 0486406-8 Auditor with principal responsibility Grönroos, Maria Alice 19.02.1967 Citizen of Finland Additional information No details about beneficial owners have been registered for the company Name history Avient Finland Oy 01.12.2020 - Clariant Plastics & Coatings (Finland) Oy 04.01.2016 - 01.12.2020 Clariant Masterbatches (Finland) Oy 31.03.2007 - 04.01.2016 Source of information: Finnish Patent and Registration Office
https://www.avient.com/sites/default/files/2021-11/polyone-cr-sro-notarial-deed-name-change-to-avient-material-solutions-cr-sro-oct-27-2021.pdf
identifikační číslo 26689537, sídlem Pobřežní 620/3, Karlín, 186 00 Praha 8, spisová značka C 87503 vedená u Městského soudu v Praze (dále též „Společnost“), o změně obsahu společenské smlouvy (dále též „Rozhodnutí“), konané dne 21.10.2021 v budově na adrese Jáchymova 26/2, Staré Město, 110 00 Praha 1. ------------------ I. 1.
Kateřiny Hájkové, LL.M., datum narození 03.06.1982, adresa místa pobytu Křižíkova 220/91, Karlín, 186 00 Praha 8, advokáta, evidenční číslo ČAK 13682, spolupracujícího s PRK Partners s.r.o., advokátní kancelář, IČO 266 92 392, se sídlem Jáchymova 26/2, Staré Město, 110 00 Praha 1, dle kterého výpis z obchodního rejstříku obsahuje stav aktuální ke dni konání valné hromady dne 21.10.2021. ----------------------------------- 2.
Kateřina Hájková, LL.M., datum narození 03.06.1982, adresa místa pobytu Křižíkova 220/91, Karlín, 186 00 Praha 8, advokáta, evidenční číslo ČAK 13682, spolupracujícího s PRK Partners s.r.o., advokátní kancelář, IČO 266 92 392, se sídlem Jáchymova 26/2, Staré Město, 110 00 Praha 1 (dále též „Předsedající“).